Alerts will be sent to your verified email
Verify Email
DLCL
|
Dr Lalchandani Labs
|
Clinitech Laboratory
|
DhanvantriJeevan Rek
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
2.8 % | 19.47 % | -2.74 % |
|
5yr average Equity Multiplier
|
1.66 | 1.81 | 1.5 |
|
5yr Average Asset Turnover Ratio
|
0.47 | 1.31 | 1.16 |
|
5yr Avg Net Profit Margin
|
1.64 % | 7.42 % | -2.7 % |
|
Price to Book
|
0.0 | 1.13 | 1.09 |
|
P/E
|
23.23 | 24.29 | 26.99 |
|
5yr Avg Cash Conversion Cycle
|
251.31 Days | -48.54 Days | 39.88 Days |
|
Inventory Days
|
61.66 Days | 10.56 Days | 2.64 Days |
|
Days Receivable
|
366.94 Days | 47.42 Days | 37.5 Days |
|
Days Payable
|
236.74 Days | 133.84 Days | -1976.44 Days |
|
5yr Average Interest Coverage Ratio
|
2.93 | 10.37 | -2.62 |
|
5yr Avg ROCE
|
6.03 % | 22.56 % | -1.98 % |
|
5yr Avg Operating Profit Margin
|
14.14 % | 16.43 % | 2.45 % |
|
5 yr average Debt to Equity
|
0.44 | 0.31 | 0.0 |
|
5yr CAGR Net Profit
|
5.7 % | -0.51 % | n/a |
|
5yr Average Return on Assets
|
2.22 % | 10.1 % | -1.85 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
31.15 % | 62.42 % | 19.65 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-29.63 % | 0.84 % | -0.12 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Dr Lalchandani Labs
|
Clinitech Laboratory
|
DhanvantriJeevan Rek
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|